Women’s health company developing the patented Callavid® platform for reliable, convenient intravaginal drug delivery
Women’s health company developing the patented Callavid® platform for reliable, convenient intravaginal drug delivery. Clinical-stage applications include fertility treatment and prevention of miscarriage and preterm birth; the platform is also being developed for delivery of live biotherapeutics to restore vaginal microbiome health and for sample collection supporting biomarker-based diagnostics. The company reports FDA clearance for its technology, while products described on its website are,,